1. Ye, Feng, Gao, Hongwei, Xiao, Lin, Cheng, Liang, Bu, Hong. 2018. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. In International journal of cancer, 144, 1321-1330. doi:10.1002/ijc.31825. https://pubmed.ncbi.nlm.nih.gov/30132833/
2. Kang, Seung-Gul, Lee, Yu Jin, Park, Young-Min, Kim, Leen, Lee, Heon-Jeong. 2018. Haplotype Association of the MAP2K5 Gene with Antipsychotics-Induced Symptoms of Restless Legs Syndrome among Patients with Schizophrenia. In Psychiatry investigation, 15, 84-89. doi:10.4306/pi.2018.15.1.84. https://pubmed.ncbi.nlm.nih.gov/29422930/
3. Lu, Ce, Wang, Hai-Jun, Song, Jie-Yun, Huang, Tao, Wang, Hui. 2022. Fine Mapping of the MAP2K5 Region Identified rs7175517 as a Causal Variant Related to BMI in China and the United Kingdom Populations. In Frontiers in genetics, 13, 838685. doi:10.3389/fgene.2022.838685. https://pubmed.ncbi.nlm.nih.gov/35368675/
4. Raizen, David M, Wu, Mark N. . Genome-wide association studies of sleep disorders. In Chest, 139, 446-452. doi:10.1378/chest.10-1313. https://pubmed.ncbi.nlm.nih.gov/21285061/
5. Li, Gen, Tang, Huidong, Wang, Cheng, Chen, Shengdi, Ma, Jianfang. . Association of BTBD9 and MAP2K5/SKOR1 With Restless Legs Syndrome in Chinese Population. In Sleep, 40, . doi:10.1093/sleep/zsx028. https://pubmed.ncbi.nlm.nih.gov/28329290/
6. Tan, Brendan Jen-Wei, Pang, Xin-Ler, Png, Sarah, Zhou, Zhi Dong, Tan, Eng-King. 2024. Genetic Association Studies in Restless Legs Syndrome: Risk Variants & Ethnic Differences. In The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, , 1-16. doi:10.1017/cjn.2024.8. https://pubmed.ncbi.nlm.nih.gov/38267254/
7. Jensen, Kevin P, Kranzler, Henry R, Stein, Murray B, Gelernter, Joel. 2014. The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 165B, 175-83. doi:10.1002/ajmg.b.32219. https://pubmed.ncbi.nlm.nih.gov/24436253/
8. Sánchez-Fdez, Adrián, Ortiz-Ruiz, María Jesús, Re-Louhau, María Florencia, Pandiella, Atanasio, Esparís-Ogando, Azucena. 2019. MEK5 promotes lung adenocarcinoma. In The European respiratory journal, 53, . doi:10.1183/13993003.01327-2018. https://pubmed.ncbi.nlm.nih.gov/30442718/